Ignite Creation Date:
2025-12-24 @ 3:41 PM
Ignite Modification Date:
2026-01-02 @ 7:54 AM
Study NCT ID:
NCT00119392
Status:
COMPLETED
Last Update Posted:
2018-06-29
First Post:
2005-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-06
Start Date Type:
None
Primary Completion Date:
2009-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-23
Completion Date Type:
ACTUAL
First Submit Date:
2005-07-12
First Submit QC Date:
None
Study First Post Date:
2005-07-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-17
Results First Submit QC Date:
None
Results First Post Date:
2017-05-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-01
Last Update Post Date:
2018-06-29
Last Update Post Date Type:
ACTUAL